ALIDABRAFENIB – Dabrafenib mesylate

$2,000.00

Dabrafenib mesylate is listed in the VetinoPharma B2B pharmaceutical product catalog under Oncology. It is commonly referenced in braf v600 mutation-positive cancer reference, often reviewed with mek inhibitor combinations within professional pharmaceutical sourcing contexts. For wholesale, distribution, or sourcing inquiries, please contact the VetinoPharma team.

- +
SKU: ALIDABRAFENIB Category: Tags: , , ,
Get a Quote

For wholesale, distribution, or sourcing inquiries, please contact our team.

Select your currency